Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Multiparametric MRI - local staging of prostate cancer and beyond.

Caglic I, Kovac V, Barrett T.

Radiol Oncol. 2019 May 8;53(2):159-170. doi: 10.2478/raon-2019-0021.

2.

Multiparametric magnetic resonance imaging for the assessment of extracapsular invasion and other staging parameters in patients with prostate cancer candidates for radical prostatectomy.

Lista F, Gimbernat H, Cáceres F, Rodríguez-Barbero JM, Castillo E, Angulo JC.

Actas Urol Esp. 2014 Jun;38(5):290-7. doi: 10.1016/j.acuro.2013.11.003. Epub 2014 Jan 1. English, Spanish.

PMID:
24387827
3.

Comparison of preoperative locoregional Ga-68 PSMA-11 PET-CT and mp-MRI results with postoperative histopathology of prostate cancer.

Yilmaz B, Turkay R, Colakoglu Y, Baytekin HF, Ergul N, Sahin S, Tugcu V, Inci E, Tasci AI, Cermik TF.

Prostate. 2019 Jun;79(9):1007-1017. doi: 10.1002/pros.23812. Epub 2019 Apr 23.

PMID:
31012125
4.

Comparison of 68Ga-PSMA-11 PET-CT with mpMRI for preoperative lymph node staging in patients with intermediate to high-risk prostate cancer.

Zhang Q, Zang S, Zhang C, Fu Y, Lv X, Zhang Q, Deng Y, Zhang C, Luo R, Zhao X, Wang W, Wang F, Guo H.

J Transl Med. 2017 Nov 7;15(1):230. doi: 10.1186/s12967-017-1333-2.

5.

Accuracy of standard clinical 3T prostate MRI for pelvic lymph node staging: Comparison to 68Ga-PSMA PET-CT.

Meißner S, Janssen JC, Prasad V, Diederichs G, Hamm B, Brenner W, Makowski MR.

Sci Rep. 2019 Jul 24;9(1):10727. doi: 10.1038/s41598-019-46386-3.

6.

One-Stop-Shop Whole-Body 68Ga-PSMA-11 PET/MRI Compared with Clinical Nomograms for Preoperative T and N Staging of High-Risk Prostate Cancer.

Thalgott M, Düwel C, Rauscher I, Heck MM, Haller B, Gafita A, Gschwend JE, Schwaiger M, Maurer T, Eiber M.

J Nucl Med. 2018 Dec;59(12):1850-1856. doi: 10.2967/jnumed.117.207696. Epub 2018 May 24.

PMID:
29794224
7.

Comparative effectiveness of [(18) F]-fluorocholine PET-CT and pelvic MRI with diffusion-weighted imaging for staging in patients with high-risk prostate cancer.

Pinaquy JB, De Clermont-Galleran H, Pasticier G, Rigou G, Alberti N, Hindie E, Mokrane Y, Fernandez P.

Prostate. 2015 Feb 15;75(3):323-31. doi: 10.1002/pros.22921. Epub 2014 Nov 12.

PMID:
25393215
8.

Multiparametric MRI in detection and staging of prostate cancer.

Boesen L.

Dan Med J. 2017 Feb;64(2). pii: B5327. Review.

PMID:
28157066
9.

Detection of recurrent prostate cancer after primary radiation therapy: An evaluation of the role of multiparametric 3T magnetic resonance imaging with endorectal coil.

Zattoni F, Kawashima A, Morlacco A, Davis BJ, Nehra AK, Mynderse LA, Froemming AT, Jeffrey Karnes R.

Pract Radiat Oncol. 2017 Jan - Feb;7(1):42-49. doi: 10.1016/j.prro.2016.06.003. Epub 2016 Jun 14.

PMID:
27527896
10.

Detection of recurrent prostate cancer after radical prostatectomy: comparison of 11C-choline PET/CT with pelvic multiparametric MR imaging with endorectal coil.

Kitajima K, Murphy RC, Nathan MA, Froemming AT, Hagen CE, Takahashi N, Kawashima A.

J Nucl Med. 2014 Feb;55(2):223-32. doi: 10.2967/jnumed.113.123018. Epub 2014 Jan 16.

11.
12.

Diffusion-weighted imaging (DWI) in lymph node staging for prostate cancer.

Caglic I, Barrett T.

Transl Androl Urol. 2018 Oct;7(5):814-823. doi: 10.21037/tau.2018.08.04. Review.

13.

Comparison of 68Ga-PSMA PET/CT and multiparametric MRI for staging of high-risk prostate cancer68Ga-PSMA PET and MRI in prostate cancer.

Tulsyan S, Das CJ, Tripathi M, Seth A, Kumar R, Bal C.

Nucl Med Commun. 2017 Dec;38(12):1094-1102. doi: 10.1097/MNM.0000000000000749.

PMID:
28957842
14.

68Ga-PSMA PET/CT Imaging Predicting Intraprostatic Tumor Extent, Extracapsular Extension and Seminal Vesicle Invasion Prior to Radical Prostatectomy in Patients with Prostate Cancer.

von Klot CJ, Merseburger AS, Böker A, Schmuck S, Ross TL, Bengel FM, Kuczyk MA, Henkenberens C, Christiansen H, Wester HJ, Solass W, Lafos M, Derlin T.

Nucl Med Mol Imaging. 2017 Dec;51(4):314-322. doi: 10.1007/s13139-017-0476-7. Epub 2017 Mar 7.

15.

[18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.

Poulsen MH, Bouchelouche K, Høilund-Carlsen PF, Petersen H, Gerke O, Steffansen SI, Marcussen N, Svolgaard N, Vach W, Geertsen U, Walter S.

BJU Int. 2012 Dec;110(11):1666-71. doi: 10.1111/j.1464-410X.2012.11150.x. Epub 2012 Apr 23.

16.

Final analysis of a prospective trial on functional imaging for nodal staging in patients with prostate cancer at high risk for lymph node involvement.

Van den Bergh L, Lerut E, Haustermans K, Deroose CM, Oyen R, Isebaert S, Budiharto T, Ameye F, Mottaghy FM, Bogaerts K, Van Poppel H, Joniau S.

Urol Oncol. 2015 Mar;33(3):109.e23-31. doi: 10.1016/j.urolonc.2014.11.008. Epub 2015 Feb 2.

PMID:
25655681
18.

Diagnostic accuracy of multiparametric magnetic resonance imaging in detecting extracapsular extension in intermediate and high - risk prostate cancer.

Dominguez C, Plata M, Cataño JG, Palau M, Aguirre D, Narvaez J, Trujillo S, Gómez F, Trujillo CG, Caicedo JI, Medina C.

Int Braz J Urol. 2018 Jul-Aug;44(4):688-696. doi: 10.1590/S1677-5538.IBJU.2016.0485.

19.

Prospective evaluation of 68Gallium-prostate-specific membrane antigen positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer.

van Leeuwen PJ, Emmett L, Ho B, Delprado W, Ting F, Nguyen Q, Stricker PD.

BJU Int. 2017 Feb;119(2):209-215. doi: 10.1111/bju.13540. Epub 2016 Jun 18.

20.

Accuracy of Magnetic Resonance Imaging for Local Staging of Prostate Cancer: A Diagnostic Meta-analysis.

de Rooij M, Hamoen EH, Witjes JA, Barentsz JO, Rovers MM.

Eur Urol. 2016 Aug;70(2):233-45. doi: 10.1016/j.eururo.2015.07.029. Epub 2015 Jul 26.

PMID:
26215604

Supplemental Content

Support Center